1. Kitahara M, Takeda T, Yazawa Y, Matsubara H, Kitano H. Treatment of Ménière's disease with isosorbide. ORL J Otorhinolaryngol Relat Spec. 1982; 44(4):232–238. PMID:
7110671.
Article
2. Juhn SK, Prado S, Pearce J. Osmolality changes in perilymph after systemic administration of glycerin. Arch Otolaryngol. 1976; 11. 102(11):683–685. PMID:
985201.
Article
3. Kakigi A, Takeda T, Saito H, Kataoka H. Effect of isosorbide on hearing loss due to endolymphatic hydrops. Acta Otolaryngol Suppl. 1995; 519:223–226. PMID:
7610874.
Article
4. Takeda T, Takeuchi S, Saito H. Effect of glycerol on pressure differences between perilymph and endolymph. Acta Otolaryngol. 1990; Jul-Aug. 110(1-2):68–72. PMID:
2386035.
5. Kakigi A, Takeda S, Takeda T, Sawada S, Azuma H, Higashiyama K, et al. Time course of dehydrating effects of isosorbide on experimentally induced endolymphatic hydrops in guinea pigs. ORL J Otorhinolaryngol Relat Spec. 2004; 66(6):291–296. PMID:
15668526.
Article
6. Klockhoff I. Diagnosis of Menière's disease. Arch Otorhinolaryngol. 1976; 9. 212(4):309–314. PMID:
990081.
Article
7. Padoan S. Oral versus i.v. administration of the glycerol test: side-effects and usefulness. Acta Otolaryngol. 2003; 5. 123(4):482–487. PMID:
12797582.
Article
8. Matsubara H, Kitahara M, Takeda T, Yazawa Y. Rebound phenomenon in glycerol test. Acta Otolaryngol Suppl. 1984; 419:115–122. PMID:
6599220.
Article
9. Larsen HC, Angelborg C, Klockoff I, Stahle J. The effect of isosorbide and urea on hearing inpatients with Ménière's disease. Acta Otolaryngol (Stockh) Suppl. 1984; 412:113–114.
10. Yamazaki T, Imoto T, Hayashi N, Watanabe S, Kozaki H, Abe T. Menière's disease and isosorbide as an oral hyperosmotic agent. Arch Otorhinolaryngol. 1982; 234(1):97–104. PMID:
7082223.
11. Nozawa I, Nakayama H, Hashimoto K, Imamura S, Hisamatu K, Murakami Y. Efficacy of long-term administration of isosorbide for Ménière's disease. ORL J Otorhinolaryngol Relat Spec. 1995; May-Jun. 57(3):135–140. PMID:
7603692.
Article
12. Kakigi A, Takeda T, Sawada S, Taguchi D. Antidiuretic hormone and osmolality in isosorbide therapy and glycerol test. ORL J Otorhinolaryngol Relat Spec. 2006; 68(5):279–282. PMID:
16699291.
Article
13. Scheibe F, Haupt H. Biochemical differences between perilymph, cerebrospinal fluid and blood plasma in the guinea pig. Hear Res. 1985; 1. 17(1):61–66. PMID:
3997682.
Article
14. Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008; 8. 372(9636):406–414. PMID:
18675691.
Article
15. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech. 1997; 2. 36(3):201–211. PMID:
9080410.
Article
16. Salt AN, Kellner C, Hale S. Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res. 2003; 8. 182(1-2):24–33. PMID:
12948598.
Article
17. Hahn H, Salt AN, Biegner T, Kammerer B, Delabar U, Hartsock JJ, et al. Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig. Otol Neurotol. 2012; 6. 33(4):660–665. PMID:
22588238.
Article
18. Iida T, Teranishi M, Yoshida T, Otake H, Sone M, Kato M, et al. Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections. Acta Otolaryngol. 2013; 5. 133(5):434–438. PMID:
23294239.
Article